Activity-Based Nanosensors of Lung Cancer

Aspects of the present disclosure relate to methods and compositions useful for in vivo and/or in vitro profiling of proteases present in the lung. In some embodiments, the disclosure provides methods of in vivo enzymatic processing of exogenous molecules followed by detection of detectable markers as representative of the presence of active proteases associated with a lung disease, for example, lung cancer and lung infections. In some embodiments, the disclosure provides compositions and methods for production of a lung disease signature and diagnosis of lung disease.

Researchers

Andrew Warren / Colin Buss / Jaideep Dudani / Jesse Kirkpatrick / Sangeeta Bhatia

Departments: Health Sciences & Technology, Health Sciences and Technology Program
Technology Areas: Biotechnology: Sensors & Monitoring / Chemicals & Materials: Nanotechnology & Nanomaterials
Impact Areas: Healthy Living

  • lung protease nanosensors and uses thereof
    United States of America | Published application
  • lung protease nanosensors and uses thereof
    European Patent Convention | Published application
  • lung protease nanosensors and uses thereof
    United States of America | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies